Navigation Links
UC San Diego researchers improve accuracy of breast cancer prognoses
Date:10/16/2007

One of the many unknowns facing women who are diagnosed with breast cancer is predicting the likelihood that the cancer will spread to other parts of the body metastasize. Researchers from UC San Diego are looking to change that. UCSD bioengineering professor Trey Ideker is pioneering a more accurate approach for predicting the risk of breast cancer metastasis in individual patients.

This work will be published online by the journal Molecular Systems Biology on Tuesday 16 October.

Distant metastases are the main cause of death among breast cancer patients, but physicians have a hard time predicting if a patients breast cancer is likely to spread.

The researchers from UCSD and the Korea Advanced Institute of Science and Technology took advantage of new protein interaction databases and identified networks of genes from breast cancer patients rather than individual genes that can be used to predict whether a breast cancer tumor is likely to spread.

Their results offer new mechanistic insights into breast cancer metastasis and are more accurate and reproducible than two sets of individual marker genes currently used to help predict the likelihood that a patients breast cancer will spread.

Over the years, large numbers of women have endured unnecessarily harsh treatments, such as aggressive chemotherapy, due to our inability to predict metastasis risks with high accuracy. One of our goals is to improve this situation, said Trey Ideker, a bioengineering professor from the UCSD Jacobs School of Engineering and the senior author of the new study.

The next step is to confirm these results in other clinical trials. It will be absolutely crucial to confirm our findings on other patient data before we think too hard about bringing this technology to the clinic, Ideker said.

The new research may also help researchers discover disease-causing genes and more precisely classify and diagnose cancer and other diseases.

Our work supports the notion that cancer is a disease of pathways, said Ideker. The keys for understanding at least some of these pathways are encoded in protein networks.

The new study uses the same gene expression data used in two well-known studies: Vijver et al. in Nature and Wang et al. in the Lancet. Each study yielded a set of about 70 single-gene markers that are now used in hospitals to help predict the likelihood of breast cancer metastasis.

We saw about a 9 percent increase in metastasis prediction accuracy over the two main sets of individual gene markers, said Ideker, who explained that his team raised metastatic prediction accuracy for breast cancer to roughly 72 percent. But there is still plenty of room for improvement, he said.

The big difference between our work and the work outlined in Vijver and Wang is that we painted the existing gene expression data onto newly available maps of protein interactions, said Ideker. Some refer to these maps as wiring diagrams.

By focusing on how the proteins within cells interact, the researchers were able to look at the aggregate behavior of genes that are connected in functional networks. This approach improved their ability to predict which tumors would spread.

Using a mathematical approach for the prediction of metastasis (involving both machine learning and dimensionality reduction), the researchers calculated the average behavior of subnetworks of proteins and used this information to uncover subnetworks that predict metastasis better than individual gene markers.

The team uncovered 149 discriminative subnetworks consisting of 618 genes from the patients from the van de Vijver et al. data set and 243 discriminative subnetworks with 906 genes from the Wang et al. data set.

Each subnetwork is suggestive of a distinct functional pathway or complex, yielding many known and novel pathway hypotheses in organisms for which sufficient protein interaction data have been measured, the authors write in their Molecular Systems Biology paper.

For example, the researchers show that a well-known breast cancer susceptibility gene, P53, plays a central role in several protein subnetworks; it interconnects many expression-responsive genes (genes that show up as potential markers in expression-only analyses). Interestingly, P53 itself does not show up as significant in conventional expression clustering or classification methods.

A key feature of our approach is the ability to identify crucial genes that fly under the radar of conventional gene expression analyses, said Ideker.

The phenotypic changes most indicative of breast cancer metastasis need not be regulated at the level of expression, the authors write.

The researchers also show that their subnetwork markers are significantly more reproducible between data sets than individual marker genes selected without network information.


'/>"/>

Contact: Rex Graham
ragraham@ucsd.edu
858-822-3075
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. Spate of smoking-related fire deaths cause concern in San Diego
2. San Diego Zoo Prepares Itself Against Bird Flu
3. Joint Center for Molecular Modeling Instituted by Burnham Institute for Medical Research & UC San Diego
4. Researchers urge caution in using ear tube surgery
5. Researchers Scale to assess the Severity of Epilepsy in Kids
6. Researchers identify the early makers of Neonatal Sepsis
7. OHSU Researchers Announce New Discovery
8. Researchers Identify Gene Connected To Bipolar Disorder
9. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
10. Researchers trick Alzheimers Enzyme
11. Researchers find new HIV hiding place
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... 03, 2016 , ... With the opioid epidemic now at the forefront, attention ... use. Alcohol and its misuse causes long-term consequences for all aspects of society, ... in those 65 years and older. In addition, there is the long term ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... DNA or RNA from a random library of sequences depending on their attraction ... or diagnostic agents. SELEX selection is commonly performed using filters, panning, or affinity ...
(Date:5/3/2016)... ... 2016 , ... Sandbox, one of the nation’s leading independent ... newly created position of executive vice president, chief creative officer.     , In his ... and LA offices. He reports to Nancy Finigan, president of those offices. , ...
(Date:5/3/2016)... ... , ... Elizabeth Murray has always loved walking one to two miles a ... shoulder and one on her arm. But she got to the point where she ... prolapse. , The valves of the heart wouldn’t close properly resulting in mitral regurgitation, ...
(Date:5/3/2016)... ... 03, 2016 , ... Excessive panting in the car or cowering when new ... often think anxiety only manifests itself as trembling or ‘tail between the legs,’ but ... that be done about it,” says Dr. Jim Lowe, technical services veterinarian for Tomlyn ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and ... ... ... ... ...
(Date:5/3/2016)...   BIOTRONIK will be exhibiting and initiating ... implant at the Heart Rhythm Society,s 37 th ... Francisco . "Physicians and hospitals ... patient care and satisfaction possible. Part of that process ... tomorrow," said Marlou Janssen , President, BIOTRONIK, Inc. ...
(Date:5/3/2016)... , May 3, 2016 ... INTP), a clinical-stage biopharmaceutical company, today announced the appointment ... and Regulatory Affairs. "Ms. Strauss-Levy has 15 ... and has established an outstanding track record, having supported ... and regulatory approval processes in the United ...
Breaking Medicine Technology: